EXPERTISE ABOUT PLATELETS
MACOPHARMA is a pharmaceutical laboratory producing medical devices and injectable sterile drugs following the good manufacturing practice (GMP), since 1977.
As transfusion expert MACOPHARMA developed a unique knowledge on platelets.
The laboratory developed the Thromboflex TXP filter, a leukocyte reduction filter for platelet concentrate prepared under buffy coat method. It conceives the Platelet Additive Solution SSP+ (PAS III-M/E*** generation) to improve storage stability of buffy-coat and apheresis Platelet Concentrates for up to seven days with maximum ratio of up to 80% SSP+ / 20% plasma. Finally, MACOPHARMA is a pioneer in pathogen reduction technology for platelet concentrates with the Theraflex UV-platelets technique.
As Transfusion medicine evolves towards new cell therapies, Macopharma has started to diversify into biotherapies and has developed a wide range of products to assist its customers in the fields of cell & tissue therapy, regenerative medicine and transplantation.
Thus the Biotherapy range of products provides solutions for every step of the cellular therapy process from collection, processing, expansion and cryopreservation of stem cells, up to the treatment and transplantation of cells or organs to patients.
Working in collaboration with cell therapy centres, biobanks, research teams and hospitals, we develop a whole range of secure disposables, ready to use media and xeno-free supplements for cell expansion.
Strong of its extensive experience on platelet MACOPHARMA developed MultiPL’, a human platelet lysate (hPL) used as cell culture medium supplement, to stimulate ex vivo expansion of mesenchymal stem/stromal cells and of a large cells diversity.
MultiPL’ is rich in proteins and growth factors necessary for cell proliferation. MultiPL’ constitutes an advantageous alternative to fetal bovine serum/fetal calf serum (FBS/FCS).